We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.07%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.3B
AUM Growth
-$803M
Cap. Flow
+$159M
Cap. Flow %
0.82%
Top 10 Hldgs %
30.79%
Holding
732
New
52
Increased
325
Reduced
233
Closed
41

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$78.3M
2
NEE icon
NextEra Energy
NEE
+$57M
3
NVDA icon
NVIDIA
NVDA
+$48M
4
BABA icon
Alibaba
BABA
+$43.4M
5
AAPL icon
Apple
AAPL
+$39M

Top Sells

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$87.5M
2
RVMD icon
Revolution Medicines
RVMD
+$45.5M
3
ABT icon
Abbott
ABT
+$44.5M
4
JPM icon
JPMorgan Chase
JPM
+$44.3M
5
IQV icon
IQVIA
IQV
+$43M

Sector Composition

Rank Sector Weight
1 Technology 32.73%
2 Healthcare 27.11%
3 Financials 9.44%
4 Consumer Discretionary 7.72%
5 Communication Services 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLTX icon
226
MoonLake Immunotherapeutics
MLTX
$1.68B
$15.2M 0.08%
818,126
+683,797
+509% +$11.3M
CRL icon
227
Charles River Laboratories
CRL
$10.6B
$14.9M 0.08%
86,430
+53,149
+160% +$9.85M
TMUS icon
228
T-Mobile US
TMUS
$206B
$14.9M 0.08%
70,798
+4,865
+7% +$999K
HON icon
229
Honeywell
HON
$72.8B
$14.4M 0.07%
63,831
-1,210
-2% -$276K
BLK icon
230
Blackrock
BLK
$161B
$14.3M 0.07%
14,880
-22,489
-60% -$23.7M
FERG icon
231
Ferguson
FERG
$43.9B
$14.3M 0.07%
61,135
-2,038
-3% -$496K
EWTX icon
232
Edgewise Therapeutics
EWTX
$4.26B
$14.1M 0.07%
447,416
-53,798
-11% -$1.55M
TEVA icon
233
Teva Pharmaceuticals
TEVA
$36.5B
$14.1M 0.07%
+467,562
New +$15M
VRDN icon
234
Viridian Therapeutics
VRDN
$2.12B
$13.9M 0.07%
711,739
-73,359
-9% -$2.18M
WMG icon
235
Warner Music
WMG
$14.6B
$13.9M 0.07%
544,520
+363,727
+201% +$10.3M
IR icon
236
Ingersoll Rand
IR
$31.7B
$13.7M 0.07%
171,320
+15,986
+10% +$1.41M
KMB icon
237
Kimberly-Clark
KMB
$35.9B
$13.4M 0.07%
139,198
-71,905
-34% -$7.36M
SYY icon
238
Sysco
SYY
$38.8B
$13.4M 0.07%
187,491
-285,893
-60% -$23.6M
MDLZ icon
239
Mondelez International
MDLZ
$76.8B
$13.3M 0.07%
230,736
-227,512
-50% -$13.2M
SBUX icon
240
Starbucks
SBUX
$119B
$13.2M 0.07%
147,497
+2,802
+2% +$265K
LOW icon
241
Lowe's Companies
LOW
$114B
$12.9M 0.07%
54,622
+2,781
+5% +$725K
HST icon
242
Host Hotels & Resorts
HST
$16.7B
$12.8M 0.07%
669,482
+84,246
+14% +$1.61M
CI icon
243
Cigna
CI
$76.8B
$12.6M 0.07%
47,149
-33,035
-41% -$9.14M
ITW icon
244
Illinois Tool Works
ITW
$78.3B
$12.6M 0.07%
48,275
-581
-1% -$158K
NET icon
245
Cloudflare
NET
$96.7B
$12.5M 0.07%
60,811
-2,275
-4% -$434K
ILMN icon
246
Illumina
ILMN
$29.1B
$12.5M 0.07%
+101,680
New +$13.4M
IEX icon
247
IDEX
IEX
$16.4B
$12.4M 0.06%
65,631
-5,248
-7% -$1.04M
BRO icon
248
Brown & Brown
BRO
$22.6B
$12.1M 0.06%
185,909
-21,414
-10% -$1.54M
EXPE icon
249
Expedia Group
EXPE
$31.8B
$12.1M 0.06%
52,230
-55,214
-51% -$13.6M
APD icon
250
Air Products & Chemicals
APD
$66B
$11.9M 0.06%
41,016
+682
+2% +$188K

Similar funds

Candriam SCA's Q1 2026 Portfolio in Review

As of Q1 2026, Candriam SCA held 732 positions worth $19.3B, down 4% from $20.1B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Candriam SCA's Q1 2026 filing shows 52 new, 325 increased, 233 reduced and 41 closed positions. Its largest new stake was Service Corp International: 360,195 shares worth $29.7M. The largest sale was Nu Holdings, an estimated $87.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2026 buy was Service Corp International: 360,195 shares worth $29.7M.
  • Candriam SCA added most to KLA in Q1 2026, an estimated $78.3M increase.
  • Candriam SCA's biggest Q1 2026 reduction was Nu Holdings, cutting an estimated $87.5M.
  • Candriam SCA fully exited Banco Macro in Q1 2026, selling an estimated $25.6M.
  • Candriam SCA's ten largest holdings make up 31% of its $19.3B portfolio in Q1 2026.
  • Candriam SCA opened 52 new positions and closed 41 in Q1 2026.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $19.3B.

Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.